South Korea - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, South Korea Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use increased 0.6% year on year. With 46.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 26 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. South Korea is overtaken by Latvia, which was ranked number 25 at 47.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Lithuania with 45.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands topped the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 46.60 |
| 2018 | 46.80 |
| 2017 | 43.00 |
| 2016 | 41.80 |
| 2015 | 46.10 |
How does South Korea rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 25 |
#25
Latvia
|
47 | 2019 | +7.5 % | +7.2 % | View data | |
| 26 |
#26
South Korea
|
47 | 2019 | -0.4 % | +0.6 % | View data | |
| 27 |
#27
Lithuania
|
46 | 2019 | +2.7 % | +4.8 % | View data | |